Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Hypoxis hemerocallidea is an African medicinal plant containing hypoxoside and rooperol as primary bioactive compounds. These compounds demonstrate blood sugar regulation and antioxidant activity through enhanced hepatic antioxidant enzyme systems.
Origin & History
Hypoxis hemerocallidea, commonly known as African potato, is a perennial herbaceous plant native to Southern Africa, particularly South Africa, belonging to the Hypoxidaceae family. The medicinal parts are primarily the corms (underground stems), from which aqueous, methanolic, or other extracts are obtained through methods like maceration or infusion in water or solvents.
Research Narrative (Provisional)
Clinical evidence is limited to preclinical animal studies and small human pharmacokinetic trials, with no human RCTs identified. Key studies include a rat diabetes model (n=60, PMID: 27403200) showing 73.3% blood glucose reduction, and a mouse colitis study (PMID: 20404038) demonstrating anti-inflammatory effects. Human data consists only of pharmacokinetic interaction studies (n=16) showing no interaction with HIV medications (PMID: 19374071).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Hypoxis hemerocallidea (African Potato) corm is not typically consumed as a food for macronutrient value but rather as a medicinal preparation. Key bioactive compounds include: • Hypoxoside: The primary norlignan diglucoside, found at approximately 3.5–5.0% dry weight in the corm; upon hydrolysis by β-glucosidase (including gut flora enzymes), it converts to the biologically active aglycone rooperol. • Rooperol: A potent dicatechol with strong antioxidant and cytotoxic properties; bioavailability is dependent on enzymatic deconjugation in the gastrointestinal tract, with oral bioavailability estimated to be moderate but variable. • Sterols and sterolins: Contains β-sitosterol (~0.05–0.1% dry weight) and its glucoside β-sitosterol glucoside (BSS:BSSG ratio approximately 100:1 in standardized extracts), which are credited with immunomodulatory activity. • Phenolic acids: Includes gallic acid, protocatechuic acid, and caffeic acid derivatives contributing to total phenolic content of approximately 15–25 mg GAE/g dry extract. • Flavonoids: Quercetin and kaempferol glycosides detected at lower concentrations (~2–5 mg/g dry extract). • Stanols and fatty acids: Minor amounts of stigmasterol and campesterol; trace long-chain fatty acids. • Minerals: Corm contains potassium (~800–1200 mg/100g dry weight), calcium (~150–300 mg/100g), magnesium (~100–200 mg/100g), iron (~5–15 mg/100g), and zinc (~2–5 mg/100g), though these values vary significantly with soil conditions and geographic origin. • Fiber: The corm is rich in dietary fiber (~30–45% dry weight), predominantly insoluble fiber including cellulose and hemicellulose. • Protein: Low protein content (~3–6% dry weight). • Carbohydrates: Starch-rich corm with total carbohydrates approximately 40–55% dry weight. • Vitamins: Limited data; trace amounts of vitamin C and B-complex vitamins have been reported. • Bioavailability notes: Hypoxoside is water-soluble and well-absorbed orally but requires enzymatic conversion to rooperol for biological activity; β-sitosterol has inherently low oral bioavailability (~5–10%) which is improved in glucoside form; traditional aqueous decoction preparation extracts primarily hypoxoside and polar phenolics while sterol extraction is enhanced with lipid-based or ethanolic preparations.
Reported Mechanism (Provisional)
Hypoxis hemerocallidea's primary bioactives hypoxoside and rooperol enhance hepatic antioxidant enzyme systems including catalase and glutathione peroxidase. The compounds appear to modulate glucose metabolism through improved insulin sensitivity pathways. These mechanisms contribute to both glycemic control and oxidative stress reduction in metabolic tissues.
Clinical Narrative (Provisional)
Current evidence for Hypoxis hemerocallidea relies primarily on animal studies rather than human trials. In diabetic rat models, 200 mg/kg aqueous extract reduced blood glucose levels by 73.3% after 6 weeks of treatment. The same studies showed significant elevation of hepatic antioxidant markers including ORAC, FRAP, and catalase activity. Human clinical data remains limited, making evidence strength preliminary at this stage.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.